Virtu Financial LLC - INNOVATE BIOPHARMACEUTICLS I ownership

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 21 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q4 2019$22,000
+22.2%
39,938
+133.9%
0.00%
+100.0%
Q3 2019$18,000
-75.3%
17,075
-72.8%
0.00%
-75.0%
Q2 2019$73,00062,8220.00%
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2019.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders